Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
4.950
-0.200 (-3.88%)
Mar 31, 2025, 3:39 PM EDT - Market open

Cara Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Cara Therapeutics stock has a target of 12, which predicts an increase of 142.42% from the current stock price of 4.95.

Analyst Consensus: Hold
Target Low Average Median High
Price $12 $12 $12 $12
Change +142.42% +142.42% +142.42% +142.42%
* Price targets were last updated on Jun 13, 2024.

Analyst Ratings

The average analyst rating for Cara Therapeutics stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222220
Buy 000000
Hold 444443
Sell 000000
Strong Sell 000000
Total 666663

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
$120$12
Hold Downgrades $120$12 +142.42% Jun 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 13, 2024
Needham
Needham
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 13, 2024
Needham
Needham
Strong Buy
Reiterates
$60
Strong Buy Reiterates $60 +1,112.12% May 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$43
Strong Buy Reiterates $43 +772.73% May 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
3.67M
from 7.14M
Decreased by -48.55%
Revenue Next Year
1.53M
from 3.67M
Decreased by -58.33%
EPS This Year
-0.79
from -15.53
EPS Next Year
-0.65
from -0.79
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
135.08M23.03M41.87M20.97M7.14M3.67M1.53M19.33M
Revenue Growth
579.28%-82.95%81.81%-49.92%-65.96%-48.55%-58.33%1,163.20%
EPS
2.13-20.93-19.12-26.26-15.53-0.79-0.65-0.73
EPS Growth
--------
Forward PE
--------
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 3.8M 1.6M 26.5M
Avg 3.7M 1.5M 19.3M
Low 3.5M 1.5M 12.4M

Revenue Growth

Revenue Growth 202520262027
High
-47.0%
-57.1%
1,629.2%
Avg
-48.5%
-58.3%
1,163.2%
Low
-50.6%
-60.0%
713.5%

EPS Forecast

EPS 202520262027
High -0.36 -0.34 -0.33
Avg -0.79 -0.65 -0.73
Low -1.11 -1.10 -1.10

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.